Iovance

Organization

Heard in 2 episodes across 2 shows since Oct 2026

Iovance Biotherapeutics is a biotechnology company developing tumor-infiltrating lymphocyte therapies for cancer.

Episodes

across 2 shows

First heard

Oct 2026

Expert statements

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data

Email alert

One email a week at most, with the new episodes that mention Iovance. Free, no account needed, unsubscribe in one click.

1 statement · 1 neutral

Ken ShreveNeutralOct 28, 2026· Stock Market Today With IBD
Iovance is not certain to double from its current price
“It doesn't mean that it's destined to double from here.”
Listen at 19:50
Open the episode · Indexes Edge Higher As Fed Stands Pat: Brinker, Medpace, Iovance In Focus

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

2 episodes featuring Iovance, newest first